No one should face hereditary cancer alone
PHOTO COURTESY GEETA SONI
Liberal MNA for Vaudreuil Marie-Claude Nichols (third from left) attends the DOvEE project raising awareness for early detection of ovarian and endometrial cancer.
Thinking about or dealing with cancer risk can be scary or overwhelming, but receiving information and resources is comforting, empowering, and lifesaving.
Punjab Sports & Cultural Association presented via The DOvEE Project (Diagnosing ovarian and endometrial cancer early) Saturday, October 8, at the Vaudreuil-Dorion Centre Multi-Sport.
It was evident that lots of time, energy and planning went into the organization of this presentation. Marie-Claude Nichols (Member of National Assembly from Vaudreuil, Quebec Liberal Party) was the guest of honour with over 70 community women attending the presentation. There was a tremendous interest in the event and the audience asked many questions of the Keynote Speakers / Conférenciers d’Honneur: Dr. Anupam Joshi MD and Joelle Malek BSN RN regarding women’s health followed by the delicious refreshments provided by the volunteers of the community.
The organizing committee would like to thank everyone who contributed to making this event so incredibly successful and would like to extend gracious thank you to our dear sponsor - Association Casa Espoir. We look forward to bringing more events in 2017 and seek continuous support from everybody involved at all levels.
Information regarding Ovarian Cancer
Close surveillance or screening for cancer on a routine basis can identify cancer early on at its most treatable stage. Surveillance doesn’t prevent cancer; however, catching cancer early improves a person’s odds of survival.
Ovarian cancer is particularly difficult to detect. Hidden deep in the abdominal cavity, ovaries are difficult to view or feel and abnormalities are not always found early. Even with the most rigorous surveillance, ovarian cancer is often detected only in its advanced stage. Even when detected early, the disease often requires aggressive treatment such as chemotherapy. For these reasons, it is important to consult with healthcare experts who are familiar with the standards of care and risk management in high-risk women.